CPT code 92605 represents a comprehensive, face-to-face evaluation (one hour) to assess a patient’s abilities and determine the most suitable non–speech–generating communication device, with caregiver input incorporated into the assessment. This code is significant nationally as it documents a specialized allied-health service—commonly delivered by speech-language pathologists—that facilitates functional communication for patients with severe expressive limitations. Proper use of CPT code 92605 can affect device selection, care planning, and downstream durable medical equipment decisions.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication presents what stakeholders need to know about coverage patterns, billing practice benchmarks, programmatic policy considerations, and the clinical context for AAC device evaluations. Readers will find national benchmarks for utilization and payment where available, summaries of payer policy trends that influence coverage of comprehensive AAC assessments, and practical clinical context about service delivery and typical settings. Where specific input was not provided, the report notes Data not available in the input. The content is intended for providers, billing professionals, and policy analysts seeking a concise, national-level briefing on CPT code 92605 and its role in assessing non–speech–generating communication devices.